SCHEMBL1089945

SCHEMBL1089945

O=S(=O)(c1ccc2ccccc2c1)N1CCC(N2CCC(Nc3nccc(N4CCCCCC4)n3)C2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.50
KDM4E B2RXH2 4/20 0.48
ALDH1A1 P00352 2/20 0.48
PKM P14618 1/20 0.48
MCOLN3 Q8TDD5 3/20 0.47
TSHR P16473 2/20 0.47
LMNA P02545 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
USP2 O75604 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
RXFP1 Q9HBX9 1/20 0.42
GAA P10253 2/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C1 Q04828 1/20 0.41
TPSAB1 Q15661 1/20 0.41
HRH4 Q9H3N8 2/20 0.40
KDM2B Q8NHM5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1091119 0.96 KDM4E (0.48) CXCR4KDM4EALDH1A1PKMMCOLN3
SCHEMBL1090671 0.96 KDM4E (0.48) CXCR4KDM4EALDH1A1PKMMCOLN3
SCHEMBL1089635 0.92 CXCR4 (0.49) CXCR4ALDH1A1MCOLN3TSHRLMNA
SCHEMBL1091155 0.90 CXCR4 (0.56) CXCR4KDM4EALDH1A1MEN1KMT2A
SCHEMBL1090458 0.88 CXCR4 (0.47) CXCR4MCOLN3TSHRMEN1KMT2A
SCHEMBL1089953 0.88 CXCR4 (0.46) CXCR4MCOLN3TSHRMEN1KMT2A
SCHEMBL1090796 0.87 CXCR4 (0.47) CXCR4KDM4EALDH1A1MAPK1RXFP1
SCHEMBL1090432 0.87 ALDH1A1 (0.53) CXCR4KDM4EALDH1A1HRH4IKBKB
SCHEMBL1090617 0.87 ALDH1A1 (0.53) CXCR4KDM4EALDH1A1PKMSMN1; SMN2
SCHEMBL1091267 0.86 ALDH1A1 (0.56) CXCR4KDM4EALDH1A1PKMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM4E 2001/4885ALDH1A1 916/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM4E 2001/4885ALDH1A1 916/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM4E 2001/4885ALDH1A1 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.